Khorana score and thromboembolic risk in stage II-III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial.

MLA

Barni, Sandro, et al. “Khorana Score and Thromboembolic Risk in Stage II-III Colorectal Cancer Patients: A Post Hoc Analysis from the Adjuvant TOSCA Trial.” Therapeutic Advances in Medical Oncology, vol. 12, Jan. 2020, p. 1758835919899850. EBSCOhost, https://doi.org/10.1177/1758835919899850.

APA

Barni, S., Rosati, G., Lonardi, S., Pella, N., Banzi, M., Zampino, M. G., Dotti, K. F., Rimassa, L., Marchetti, P., Maiello, E., Artioli, F., Ferrari, D., Labianca, R., Bidoli, P., Zaniboni, A., Sobrero, A., Iaffaioli, V., De Placido, S., Frassineti, G. L., … Petrelli, F. (2020). Khorana score and thromboembolic risk in stage II-III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial. Therapeutic Advances in Medical Oncology, 12, 1758835919899850. https://doi.org/10.1177/1758835919899850

Chicago

Barni, Sandro, Gerardo Rosati, Sara Lonardi, Nicoletta Pella, Maria Banzi, Maria G Zampino, Katia F Dotti, et al. 2020. “Khorana Score and Thromboembolic Risk in Stage II-III Colorectal Cancer Patients: A Post Hoc Analysis from the Adjuvant TOSCA Trial.” Therapeutic Advances in Medical Oncology 12 (January): 1758835919899850. doi:10.1177/1758835919899850.